Torrent Pharmaceuticals Q2 FY27 results on 23 Oct
Key Highlights
Torrent Pharmaceuticals meets on 23 Oct for Q2 FY27 results. The company reported a net profit of ₹566 crore and revenue of ₹4,921 crore in Q1 FY27.
Updated: Thursday 22 October 2026
- Torrent Pharmaceuticals reports its Q2 FY27 results on Friday 23 October 2026.
- The base: net profit of ₹591 crore in Q2 FY26.
- Latest reported quarter, Q1 FY27: net profit of ₹566 crore, 3.28% higher than a year earlier.
- On its last 2 results, the shares moved +5.15%, +0.68%.
Torrent Pharmaceuticals Q2 FY27 results date is set for the board meeting on 23 October 2026. The company will review its performance for the quarter ended 30 September 2026.
In the same quarter a year earlier, the company reported a net profit of ₹591 crore. from operations for that period stood at ₹3,302 crore.
When does Torrent Pharmaceuticals announce its Q2 FY27 results?
| Board meeting on results | Friday 23 October 2026 |
| Quarter | Q2 FY27 (ended 30 September 2026) |
| Notice filed with the exchange | 6 Oct 2026 |
Torrent Pharmaceuticals’s reported quarters
| Quarter | Revenue from operations | Net profit | Net profit margin | ||
|---|---|---|---|---|---|
| Q2 FY26 | 3,302 | 791 | 591 | 17.90% | The quarter these results are set against |
| Q3 FY26 | 3,303 | 814 | 635 | 19.22% | |
| Q4 FY26 | 4,197 | 529 | 364 | 8.67% | |
| Q1 FY27 | 4,921 | 733 | 566 | 11.50% |
In the most recent quarter, Q1 FY27, the company recorded a net profit of ₹566 crore. This compares to a net profit of ₹591 crore in the same quarter a year earlier. The net profit margin was 11.50% in Q1 FY27, compared to 17.90% in the base quarter.
What to watch in the Torrent Pharmaceuticals Q2 FY27 results
| Q2 FY26 (base) | Q1 FY27 (latest reported) | Change | |
|---|---|---|---|
| Revenue from operations | 3,302 | 4,921 | +49.03% |
| Net profit | 591 | 566 | −4.23% |
| Net profit margin | 17.90% | 11.50% | −6.40 pts |
The upcoming results will be measured against the performance from Q2 FY26. In that base quarter, the company reported revenue from operations of ₹3,302 crore. The net profit margin for that period was 17.90%.
- Margin: net profit was 11.50% of revenue in Q1 FY27 and 17.90% in Q2 FY26.
- Revenue from operations: ₹4,921 crore in Q1 FY27, 54.85% higher than a year earlier.
- Share price: on the last 2 results it moved +5.15% (Q1 FY27), +0.68% (Q4 FY26), measured from the last close before the filing to the next close.
This preview uses the company’s own reported figures. It does not carry analyst estimates, so it does not say whether the results will be above or below anyone’s expectation.
How Torrent Pharmaceuticals shares moved on its earlier results
| Quarter | Results filed | Window | Change |
|---|---|---|---|
| Q1 FY27 | 30 Jul 2026 | 30 Jul 2026 to 31 Jul 2026 | +5.15% |
| Q4 FY26 | 22 May 2026 | 8 May 2026 to 29 May 2026 | +0.68% |
| Last close (Wednesday 21 October 2026) | ₹4,553.80 |
| Over the last month (21 sessions) | −5.91% |
| Over the last three months (63 sessions) | −9.66% |
Shares of Torrent Pharmaceuticals moved 5.15% higher on the release of the Q1 FY27 results. The share price moved 0.68% higher on the Q4 FY26 results. The share price closed at ₹4,553.80 on 21 October 2026.
Torrent Pharmaceuticals dividend history
| Ex-dividend date | Per share | Type |
|---|---|---|
| 29 May 2026 | ₹9.00 | Final |
Torrent Pharmaceuticals Q2 FY27 results date: FAQs
When will Torrent Pharmaceuticals announce its Q2 FY27 results?
Torrent Pharmaceuticals’s board meets on Friday 23 October 2026 to consider the results for the quarter ended 30 September 2026, according to its notice to the exchange.
What was Torrent Pharmaceuticals’s net profit in Q2 FY26?
Torrent Pharmaceuticals reported a net profit of ₹591 crore on revenue from operations of ₹3,302 crore in Q2 FY26 (consolidated figures). The Q2 FY27 results will be set against this quarter.
What was Torrent Pharmaceuticals’s latest reported net profit?
Net profit was ₹566 crore in Q1 FY27, 3.28% higher than a year earlier, or 11.50% of revenue.
How did Torrent Pharmaceuticals shares react to its last results?
Q1 FY27: +5.15%; Q4 FY26: +0.68%. Each is measured from the last close before the results were filed to the next close.
The meeting date is from the company’s notice to the exchange; results are its filings; prices are from the National Stock Exchange. Calculations are by ThePip. For information only; not investment advice.